MML Investors Services
ALNY icon

MML Investors Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

MML Investors Services’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3M Sell
9,949
-5,533
-36% -$1.67M 0.01% 1283
2026
Q1 		$5.12M Sell
15,482
-2,168
-12% -$738K 0.01% 805
2025
Q4 		$7.02M Sell
17,650
-2,028
-10% -$898K 0.02% 716
2025
Q3 		$8.97M Buy
19,678
+1,840
+10% +$749K 0.02% 588
2025
Q2 		$5.82M Buy
17,838
+4,911
+38% +$1.36M 0.02% 728
2025
Q1 		$3.49M Buy
12,927
+2,189
+20% +$563K 0.01% 896
2024
Q4 		$2.53M Buy
10,738
+7,652
+248% +$2.01M 0.01% 1009
2024
Q3 		$849K Buy
3,086
+166
+6% +$43.2K ﹤0.01% 1542
2024
Q2 		$710K Sell
2,920
-1,249
-30% -$197K ﹤0.01% 1588
2024
Q1 		$623K Buy
4,169
+217
+5% +$36.2K ﹤0.01% 1674
2023
Q4 		$756K Buy
3,952
+947
+32% +$161K ﹤0.01% 1519
2023
Q3 		$532K Sell
3,005
-261
-8% -$49.8K ﹤0.01% 1597
2023
Q2 		$620K Buy
3,266
+604
+23% +$120K ﹤0.01% 1499
2023
Q1 		$533K Buy
2,662
+250
+10% +$52.5K ﹤0.01% 1377
2022
Q4 		$573K Buy
2,412
+645
+37% +$138K ﹤0.01% 1438
2022
Q3 		$354K Sell
1,767
-8,148
-82% -$1.55M ﹤0.01% 1596
2022
Q2 		$1.45M Buy
9,915
+654
+7% +$92.8K 0.01% 877
2022
Q1 		$1.51M Buy
9,261
+218
+2% +$33.2K 0.01% 907
2021
Q4 		$1.53M Buy
9,043
+814
+10% +$151K 0.01% 880
2021
Q3 		$1.55M Buy
8,229
+562
+7% +$105K 0.01% 832
2021
Q2 		$1.3M Buy
7,667
+440
+6% +$64.4K 0.01% 892
2021
Q1 		$1.02M Buy
+7,227
New +$1.09M 0.01% 914

Other funds holding ALNY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

MML Investors Services's ALNY Position: Q2 2026 in Review

MML Investors Services reduced its Alnylam Pharmaceuticals (ALNY) stake by 36% in Q2 2026, selling an estimated $1.67M and leaving 9,949 shares worth $3M. The position accounts for 0.01% of the portfolio, ranked #1283.

MML Investors Services first reported a position in ALNY in Q1 2021 and has held it in 22 quarters since. The position peaked at $8.97M in Q3 2025. 388 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • MML Investors Services held 9,949 shares of Alnylam Pharmaceuticals worth $3M as of Q2 2026.
  • MML Investors Services sold 5,533 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $1.67M.
  • Alnylam Pharmaceuticals made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #1283 holding.
  • MML Investors Services first reported a position in Alnylam Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • MML Investors Services's Alnylam Pharmaceuticals position peaked at $8.97M in Q3 2025.
  • 388 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.